CINCINNATI, Oct. 1 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL - News), a leading, global full-service clinical research organization, today announced the appointment of Ken Hintze, PhD, as Vice President, Global Clinical Safety and Pharmacovigilance. Dr. Hintze will lead the continued growth and development of Kendle’s global clinical safety and pharmacovigilance business, including safety services in support of Phase I-IV trials as well as stand- alone safety projects. Dr. Hintze most recently was Senior Director, Global Clinical Safety and Pharmacovigilance and has been instrumental in advancing Kendle’s safety organization to the global resource it is today.
